In a cross-sectional review, 41% of patients with MIDD were classified as non-insulin dependent, whereas 13% required insulin from the time of diagnosis and 8% presented in diabetic ketoacidosis (30). The gene discussed is INS; the disease is diabetic ketoacidosis.